Among several transcription factors involved in de novo lipogenesis in liver and contributing to liver steatosis, PPAR-γ [156] and its coactivator PGC-1α drew attention in epigenetics research associated with NAFLD and its progression [[156], [157], [158], [159]]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.